Amneal Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Amneal Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2023.
  • Amneal Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$73.4M, a 39.3% decline year-over-year.
  • Amneal Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$311M, a 63% decline year-over-year.
  • Amneal Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$245M, a 59.7% decline from 2022.
  • Amneal Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$153M, a 26.2% decline from 2021.
  • Amneal Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$121M, a 4.4% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$245M -$91.4M -59.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$153M -$31.8M -26.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$121M +$5.59M +4.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 -$127M -$155M -546% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-03
2019 $28.4M +$211M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$183M -$109M -148% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$73.8M -$3.72M -5.31% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$70.1M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.